# Design Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 11, 2026

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 21:28 ET
- Period: not reported
- Accession: 0001072613-26-000257
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000107261326000257/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000107261326000257/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000107261326000257/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001072613-26-000257. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
